Gene Expression Literature Detail
|
Symbol Name ID |
Tagln
transgelin MGI:106012 |
|
Reference
|
J:310741 Briot A, Jaroszewicz A, Warren CM, Lu J, Touma M, Rudat C, Hofmann JJ, Airik R, Weinmaster G, Lyons K, Wang Y, Kispert A, Pellegrini M, Iruela-Arispe ML, Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells. Dev Cell. 2014 Dec 22;31(6):707-21 |
Indicates gene expression was analyzed but not necessarily detected.
| Age | E13 | E14.5 | E17.5 | P |
| Immunohistochemistry (section) | ||||
| In situ RNA (section) | ||||
| Immunohistochemistry (whole mount) | ||||
| In situ RNA (whole mount) | ||||
| In situ reporter (knock in) | ||||
| Northern blot | ||||
| Western blot | ||||
| RT-PCR | |
|
|
|
| cDNA clones | ||||
| RNase protection | ||||
| Nuclease S1 | ||||
| Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|
|
||
Analysis Tools